PL2604691T3 - Środki i sposoby przeciwdziałania, opóźniania i/lub zapobiegania włączaniu niekorzystnego metabolizmu energetycznego w chorobach serca - Google Patents
Środki i sposoby przeciwdziałania, opóźniania i/lub zapobiegania włączaniu niekorzystnego metabolizmu energetycznego w chorobach sercaInfo
- Publication number
- PL2604691T3 PL2604691T3 PL13158674T PL13158674T PL2604691T3 PL 2604691 T3 PL2604691 T3 PL 2604691T3 PL 13158674 T PL13158674 T PL 13158674T PL 13158674 T PL13158674 T PL 13158674T PL 2604691 T3 PL2604691 T3 PL 2604691T3
- Authority
- PL
- Poland
- Prior art keywords
- counteracting
- delaying
- methods
- heart disease
- energy metabolism
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1138—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against receptors or cell surface proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/11—Antisense
- C12N2310/113—Antisense targeting other non-coding nucleic acids, e.g. antagomirs
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/14—Type of nucleic acid interfering N.A.
- C12N2310/141—MicroRNAs, miRNAs
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2320/00—Applications; Uses
- C12N2320/30—Special therapeutic applications
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Cardiology (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP09788267A EP2462228A1 (en) | 2009-08-06 | 2009-08-06 | Means and methods for counteracting, delaying and/or preventing adverse energy metabolism switches in heart disease |
PCT/NL2009/050484 WO2011016714A1 (en) | 2009-08-06 | 2009-08-06 | Means and methods for counteracting, delaying and/or preventing adverse energy metabolism switches in heart disease |
EP13158674.5A EP2604691B1 (en) | 2009-08-06 | 2009-08-06 | Means and methods for counteracting, delaying and/or preventing adverse energy metabolism switches in heart disease |
Publications (1)
Publication Number | Publication Date |
---|---|
PL2604691T3 true PL2604691T3 (pl) | 2015-05-29 |
Family
ID=41503694
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL13158674T PL2604691T3 (pl) | 2009-08-06 | 2009-08-06 | Środki i sposoby przeciwdziałania, opóźniania i/lub zapobiegania włączaniu niekorzystnego metabolizmu energetycznego w chorobach serca |
Country Status (6)
Country | Link |
---|---|
US (2) | US8815822B2 (pl) |
EP (2) | EP2604691B1 (pl) |
CA (1) | CA2770130C (pl) |
ES (1) | ES2531964T3 (pl) |
PL (1) | PL2604691T3 (pl) |
WO (1) | WO2011016714A1 (pl) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2531964T3 (es) | 2009-08-06 | 2015-03-23 | Universiteit Maastricht | Medios y métodos para contrarrestar, demorar y/o prevenir cambios adversos del metabolismo energético en enfermedades del corazón |
WO2012115987A2 (en) * | 2011-02-21 | 2012-08-30 | The Trustees Of Columbia University In The City Of New York | Methods for Treating and Preventing Cardiac Dysfunction in Septic Shock |
ITRM20110685A1 (it) | 2011-12-23 | 2013-06-24 | Internat Ct For Genetic En Gineering And | Microrna per la rigenerazione cardiaca attraverso l induzione della proliferazione dei miociti cardiaci |
CN108524534A (zh) * | 2018-05-15 | 2018-09-14 | 南京市儿童医院 | miR-214拮抗剂在制备治疗高血压产品中的应用 |
CN110885824B (zh) * | 2019-12-11 | 2021-12-07 | 武汉大学 | miRNA-199核酸抑制物及其在翼状胬肉中的应用 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7683036B2 (en) * | 2003-07-31 | 2010-03-23 | Regulus Therapeutics Inc. | Oligomeric compounds and compositions for use in modulation of small non-coding RNAs |
US7772389B2 (en) * | 2004-02-13 | 2010-08-10 | Rockefeller University | Anti-microRNA oligonucleotide molecules |
US20100286044A1 (en) * | 2005-12-29 | 2010-11-11 | Exiqon A/S | Detection of tissue origin of cancer |
EP2094869B1 (de) * | 2006-10-09 | 2012-07-25 | Julius-Maximilians-Universität Würzburg | Microrna (mirna) zur diagnose und therapie von herzerkrankungen |
ES2689508T3 (es) * | 2007-10-04 | 2018-11-14 | Roche Innovation Center Copenhagen A/S | Micromir |
US20110152352A1 (en) * | 2008-06-10 | 2011-06-23 | Tufts University | Smad proteins control drosha-mediated mirna maturation |
US20110086348A1 (en) * | 2009-02-19 | 2011-04-14 | The Cleveland Clinic Foundation | Method for assessing heart disease |
US20100292278A1 (en) * | 2009-05-15 | 2010-11-18 | Yochai Birnbaum | Methods of treating vascular disease and injury |
US9072765B2 (en) * | 2009-05-20 | 2015-07-07 | Board Of Regents, The University Of Texas System | Identification of micro-RNAs involved in post-myocardial infarction remodeling and heart failure |
ES2531964T3 (es) | 2009-08-06 | 2015-03-23 | Universiteit Maastricht | Medios y métodos para contrarrestar, demorar y/o prevenir cambios adversos del metabolismo energético en enfermedades del corazón |
-
2009
- 2009-08-06 ES ES13158674.5T patent/ES2531964T3/es active Active
- 2009-08-06 WO PCT/NL2009/050484 patent/WO2011016714A1/en active Application Filing
- 2009-08-06 EP EP13158674.5A patent/EP2604691B1/en not_active Not-in-force
- 2009-08-06 PL PL13158674T patent/PL2604691T3/pl unknown
- 2009-08-06 US US13/389,236 patent/US8815822B2/en not_active Expired - Fee Related
- 2009-08-06 CA CA2770130A patent/CA2770130C/en not_active Expired - Fee Related
- 2009-08-06 EP EP09788267A patent/EP2462228A1/en not_active Withdrawn
-
2014
- 2014-07-16 US US14/333,207 patent/US9611480B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CA2770130C (en) | 2018-02-27 |
US9611480B2 (en) | 2017-04-04 |
CA2770130A1 (en) | 2011-02-10 |
US8815822B2 (en) | 2014-08-26 |
US20140357699A1 (en) | 2014-12-04 |
ES2531964T3 (es) | 2015-03-23 |
EP2462228A1 (en) | 2012-06-13 |
EP2604691B1 (en) | 2014-12-03 |
US20120141442A1 (en) | 2012-06-07 |
WO2011016714A1 (en) | 2011-02-10 |
EP2604691A1 (en) | 2013-06-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2395938A4 (en) | Components for use with implants, and related methods | |
IL201267A0 (en) | Article, laminate and associated methods | |
EP2249922A4 (en) | DEVICES, METHODS AND SYSTEMS FOR RECOVERING BODY ENERGY | |
GB2467421B (en) | Removable security modules and related methods | |
EP2462635A4 (en) | THERMOELECTRIC MODULES, THERMOELECTRIC MODULES AND CORRESPONDING METHODS | |
EP2511029A4 (en) | METAL MATRIX COMPOSITE AND MANUFACTURING METHOD THEREFOR | |
IL218973A0 (en) | Cofactors and methods for usa for individuals | |
EP2361762A4 (en) | METHOD FOR THE PRODUCTION OF A LAMINATED BODY AND LAMINATED BODY | |
SG10201405455UA (en) | Cells and methods for obtaining them | |
EP2287239A4 (en) | POLYIMIDE-METAL LAMINATE AND SOLAR CELL | |
HUE036831T2 (hu) | Ötvözet, bevonat és azokkal kapcsolatos eljárások | |
EP2195032A4 (en) | ANTIOXIDANT ACTIVITY AND DETOXIFICATION OF PHASE II | |
EP2162458A4 (en) | PROTEIN KINASE BINDING NUCLEOSIDES AND RELATED METHODS | |
PL2604691T3 (pl) | Środki i sposoby przeciwdziałania, opóźniania i/lub zapobiegania włączaniu niekorzystnego metabolizmu energetycznego w chorobach serca | |
PL2406070T5 (pl) | Elastyczny laminat, zwłaszcza do elastycznych elementów zapinających pieluchy | |
GB0817864D0 (en) | Nut locker | |
EP2297306A4 (en) | HUMAN FACILITATING CELLS | |
HK1140772A1 (en) | Ginsenoside, preparation method thereof and use thereof | |
GB2465973B (en) | Improvements in Laced Closures | |
GB2459082B (en) | Improvements in artificial lift mechanisms | |
EP2150817A4 (en) | PROCEDURE FOR REDUCING VIRUS LOAD IN HIV-1 INFECTED PATIENTS | |
ZA201207761B (en) | Method for inhibiting hiv replication in mammal and human cells | |
ZA201108855B (en) | Wellness shoe and method | |
EP2510956A4 (en) | FAT CELL LAYER, THREE-DIMENSIONAL STRUCTURE THEREFOR AND METHOD OF MANUFACTURING THEREOF | |
IL201346A0 (en) | Newcompositions and methods for cell killing |